Drug Type Small molecule drug |
Synonyms 5-Nitro-2-furaldehyde semicarbazone, Furacilin, Furancilin + [7] |
Target |
Mechanism PFOR inhibitors(Pyruvate synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (04 Oct 1945), |
Regulation- |
Molecular FormulaC6H6N4O4 |
InChIKeyIAIWVQXQOWNYOU-UHFFFAOYSA-N |
CAS Registry59-87-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hemorrhage | CN | 01 Jan 1988 | |
Burns | CN | 01 Jan 1981 | |
Dacryocystitis | CN | 01 Jan 1981 | |
Dermatitis | CN | 01 Jan 1981 | |
Skin Diseases | US | 04 Oct 1945 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Superficial bacterial infection of skin | Phase 3 | CN | 09 Jul 2012 |